AmeriCann Inc. (OTCMKTS: ACAN) is a vertically integrated alternative agriculture company focused on the cultivation, processing and manufacture of cannabis and hemp-derived products. The company’s core operations include greenhouse cultivation, extraction, product formulation and packaging, enabling it to serve both medical and adult-use markets. Its flagship cultivation facility in Scarborough, Maine, spans over 48,000 square feet and is designed to operate under sustainable, low-cost greenhouse conditions.
In addition to growing and processing its own branded products, AmeriCann provides contract cultivation and extraction services to third-party producers, offering turnkey solutions from seed to sale. The company’s extraction lab applies CO2 and ethanol extraction technologies to produce oils, distillates and other concentrates, which can be further formulated into tinctures, edibles and topicals. Quality control measures, including on-site lab testing and adherence to Good Manufacturing Practices (GMP), underpin the company’s focus on consistency and compliance.
Formed in 2014 through a reverse merger, AmeriCann has pursued strategic expansion in New England and is exploring opportunities in other regulated U.S. markets. While the company’s management team maintains experience in agriculture, life sciences and finance, publicly available details on individual leadership roles are limited. AmeriCann continues to leverage its integrated platform to support emerging cannabis and hemp operators, positioning itself as a service provider and product innovator within the industry.
AI Generated. May Contain Errors.
